Cargando…
Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
INTRODUCTION: IFN-α intervention may block SARS-CoV-2 replication and normalize the deregulated innate immunity of COVID-19. AIM: This meta-analysis aimed to investigate the efficacy of interferon IFN-α–containing regimens when treating patients with moderate-to-severe COVID-19. MATERIAL AND METHODS...
Autores principales: | Buchynskyi, Mykhailo, Kamyshna, Iryna, Lyubomirskaya, Katerina, Moshynets, Olena, Kobyliak, Nazarii, Oksenych, Valentyn, Kamyshnyi, Aleksandr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909279/ https://www.ncbi.nlm.nih.gov/pubmed/36776844 http://dx.doi.org/10.3389/fimmu.2023.1069894 |
Ejemplares similares
-
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
por: Kamyshnyi, Aleksandr, et al.
Publicado: (2023) -
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023) -
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023) -
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023) -
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
por: Petakh, Pavlo, et al.
Publicado: (2022)